No pain, no gain: Plausibility in Warner-Lambert v Actavis By Dr Rose Hughes at Monday, November 26, 2018 lyrica no pain no gain plausibility Pregabalin Second medical use Warner-Lambert +
Friday Fantasies By Dr Rose Hughes at Friday, October 05, 2018 article 13 EUTM CJEU and copyright copyright directive EU trade secrets directive green technology IP and Entertainment IPAN Pregabalin rules of procedure +
Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle By Eleonora Rosati at Thursday, February 22, 2018 abuse of process actavis construction Eleonora Rosati indirect infringement lyrica mylan Patent amendment plausibility Pregabalin Second medical use swiss form claim uk supreme court +
AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringement By David Brophy at Thursday, December 08, 2016 abuse of process AIPPI UK seminar amendment lyrica plausibility Pregabalin Second medical use skinny label Warner-Lambert +
Pharma, Pain and Punditry: Mark your calendar for AIPPI's end of year events By Annsley Merelle Ward at Tuesday, November 15, 2016 AIPPI AIPPI UK Mr Justice Arnold pharma Pregabalin recap Warner-Lambert +
Never Too Late: If you missed the IPKat last week! By Tian Lu at Wednesday, November 02, 2016 Copyright in buildings and artwork in public places non-compete clauses pfizer Pregabalin procedural fairness Swiss claims the penalties regulation Tian Lu trade mark judges unlicensed content +
Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again By Darren Smyth at Monday, October 24, 2016 actavis mylan pfizer Pregabalin Second medical use Swiss claims Warner-Lambert +